U.S. Medical Equipment Stock News

For investors considering whether Viasat at around US$75.27 offers value or reflects stretched expectations, this article examines what the recent share price suggests about the stock and what might still be missing from the picture. The stock has seen sharp moves recently, with a 6.6% return over the past week, 17.5% over the past month, 100.0% year to date, and a very large 1 year return of 651.9%. These price swings sit against a backdrop of ongoing interest in satellite connectivity and...

In early May 2026, Consolidated Edison, Inc. reported first-quarter 2026 results showing year-over-year increases in revenue to US$5,095 million and net income to US$924 million, and shortly afterward filed for a US$2 billion at-the-market follow-on common equity offering. The combination of stronger quarterly earnings per share and plans to raise additional equity capital gives investors fresh information on both profitability and future financing needs. Next, we will examine how...

Recent commentary has highlighted Antero Midstream’s extensive gathering pipelines, compressor stations, and water management systems in the Appalachian shale region, as well as discussions about its potential inclusion in the Russell 1000 index. This renewed focus on the company’s core midstream infrastructure underlines how its role in Appalachian natural gas logistics is increasingly shaping market attention and investor interest. We’ll now examine how the increased attention around...

In May 2026, POET Technologies Inc. closed a US$400.00 million registered direct follow-on offering of 19,047,620 common shares and the same number of warrants, shortly after announcing a multi-year joint development and supply agreement with Lumilens that includes an initial US$50 million order and potential purchases up to US$500 million. By tying a nine-year warrant package to Lumilens’ spending milestones, POET has directly aligned equity incentives with the ramp-up of its AI photonics...

In recent weeks, JetBlue Airways announced that its Blue Sky collaboration with United Airlines has moved into a new phase, giving eligible TrueBlue and MileagePlus members reciprocal perks such as priority boarding, extra-legroom access, preferred seating, baggage benefits, and same-day standby when flying across either carrier’s network. By tying together loyalty programs and interline bookings, the Blue Sky partnership deepens customer engagement and could strengthen United’s...

Voya Financial (VOYA) is trading near its 52-week high, with recent momentum linked to steady contributions from its Retirement, Investment Management, and Employee Benefits segments, as well as continued share repurchases and dividends. See our latest analysis for Voya Financial. The recent 9.1% 1 month share price return and 10.7% 3 month share price return suggest momentum is building, while the 26.3% 1 year total shareholder return points to steadily improving sentiment over a longer...

Steel Dynamics (STLD) is back in focus after Q1 2026 results showed net income of $403 million alongside record steel shipments and expanding margins, with management outlining a confident outlook for the rest of the year. See our latest analysis for Steel Dynamics. The recent Q1 release and confirmed second quarter dividend have kept Steel Dynamics on investors' radar, with the share price at $228.30 and a 30 day share price return of 9.05% contributing to a 1 year total shareholder return...

In recent months, Summit Therapeutics has drawn attention for advancing ivonescimab, a bispecific antibody in late-stage development for non-small cell lung cancer and colorectal cancer, while remaining unprofitable and continuing to post negative earnings. The company’s heavy R&D investment and focus on therapies with potential benefits for patients, caregivers, and society are reshaping how some market participants view its long-term role in global oncology treatment. We’ll now examine how...

Fidelity National Information Services stock: why recent performance has investors watching closely Fidelity National Information Services (FIS) has drawn attention after a period of weaker share performance, with the stock down over the past month, past 3 months, year to date, and past year. At a last close of US$42.69 and a market cap of about US$22.5b, the company sits against a backdrop of annual revenue of US$11.44b and net income of US$2.67b. See our latest analysis for Fidelity...

LightPath Technologies reported past third-quarter 2026 results showing sales of US$19.15 million versus US$9.17 million a year earlier, while quarterly net loss widened to US$4.11 million from US$3.58 million. Over the first nine months of the fiscal year, sales more than doubled to US$50.56 million as losses also increased, highlighting the tension between rapid top-line expansion and the cost of building out its optics and infrared solutions business. With revenue more than doubling year...

ACV Auctions (ACVA) is in focus after the company expanded its ACV MAX inventory intelligence suite, bringing together inspection data, guarantees, and real-time market insights into a single platform for auto dealers. See our latest analysis for ACV Auctions. Recent ACV MAX updates and upcoming conference appearances sit against a mixed trading picture, with a 16.86% 30 day share price return contrasting with a 28.11% year to date share price decline and a 63.50% drop in 1 year total...

Earlier in May 2026, International Seaways, Inc. reported first-quarter results showing revenue of US$325.48 million and net income of US$286.14 million, declared a combined regular and supplemental dividend of US$4.55 per share payable on June 26, 2026, and filed for a US$200 million at-the-market follow-on equity offering. Alongside these results, the company’s leadership continued pre-arranged share sales and completed its existing buyback program, highlighting an active approach to...

Dorman Products (DORM) is back on investors’ radar after recent trading left the stock around $117.02, with performance mixed between the past month and the past three months. Here is what current figures reveal. See our latest analysis for Dorman Products. Recent trading has pushed the 1 day share price return to 3.71% and the 1 month share price return to 4.88%. However, the year to date share price return is still down 5.71% and the 1 year total shareholder return has declined 7.44%, while...

In its second-quarter 2026 results, Spectrum Brands Holdings reported higher sales of US$708.9 million and net income of US$22.1 million compared with the prior year, alongside sharply improved earnings per share from continuing operations. Management also highlighted a healthy balance sheet and reiterated plans to pursue disciplined acquisitions in its Pet and Home & Garden segments, positioning the company as a potential consolidator in those categories. We’ll now examine how Spectrum...

Earlier in May 2026, Remitly Global, Inc. expanded its Remitly Business offering with new Bulk Payments and Send by Link features for US small and medium-sized businesses, alongside continued rollouts in Canada and the UK and new regulatory approvals in Canada. These additions build on strong early traction for Remitly Business, which is already serving more than 20,000 companies and leveraging the same compliance and disbursement infrastructure used by 9.6 million quarterly active...

If you are wondering whether Somnigroup International at US$65.69 still offers value, it helps to break the story down into recent returns, news flow, and what the numbers say about price versus fundamentals. The stock has been volatile, with a 2.7% gain over the last week but a decline of 22.3% over the past month, while the 1 year return sits at 2.5% and the 3 and 5 year returns are 80.9% and 87.2% respectively. Recent coverage has focused on how Somnigroup International fits within the...

Taysha Gene Therapies recently advanced its lead gene therapy candidate TSHA-102 for Rett syndrome into pivotal development, supported by encouraging early clinical data and FDA Breakthrough Therapy Designation. This combination of regulatory recognition and progress in a condition with significant unmet need could materially influence how investors view Taysha’s long-term opportunity set. We’ll now examine how FDA Breakthrough Therapy Designation for TSHA-102 shapes Taysha Gene Therapies’...

Earlier in May 2026, Donaldson Company extended its more than 30-year record of dividend growth by announcing another increase, supported by solid cash flow and a continued focus on shareholder returns. This dividend hike comes despite insiders selling about US$3.5 million of stock over the past three months, a contrast that investors are watching closely. We’ll now examine how Donaldson’s fresh dividend increase and ongoing cash return stance may influence its broader investment...

At its May 2026 Annual Meeting, LKQ Corporation’s stockholders approved amendments to the company’s charter and bylaws granting holders of at least a combined 25% of common stock the right to request a special stockholder meeting, with these changes becoming effective upon filing in Delaware on May 8, 2026. These governance changes arrive as LKQ faces multiple class action securities lawsuits alleging misleading disclosures around its FinishMaster acquisition and related operational impacts,...

At its Annual General Meeting on May 15, 2026, BioNTech SE shareholders approved expanding the Supervisory Board from six to eight members, electing Prof. Iris Löw-Friedrich and Dr. Susanne Schaffert, both bringing extensive experience in clinical development, oncology, commercialization, and international healthcare markets. The addition of these two industry veterans strengthens BioNTech’s governance bench at a time when clinical execution and oncology-focused commercialization...

Ternium S.A. previously approved at its May 12, 2026 AGM an annual dividend of US$2.20 per ADS (US$0.22 per share), including a US$0.90 per ADS interim payment, with a remaining net dividend of US$1.30 per ADS payable on May 15, 2026 to shareholders of record on May 14, 2026. This dividend decision, including the balance between interim and final payouts, offers investors a window into how management is currently prioritizing cash returns versus reinvestment. We will now examine how this...

In recent analysis of Trinity Industries, investors learned that the company’s railcar backlog has fallen by an average 25.8% over the past two years, while its gross margins trail key competitors in North America. This combination of shrinking orders and thinner margins raises questions about Trinity’s ability to fund growth initiatives and maintain its competitive position in the railcar market. We’ll now examine how the weaker order backlog reshapes Trinity Industries’ existing investment...

Eastman Chemical recently announced that its Kingsport, Tennessee facility achieved ISO 59014 certification for its material-to-material methanolysis recycling technology, formally recognizing the site’s transparency, traceability, and responsible secondary material recovery practices. This third-party validation strengthens Eastman’s position in molecular recycling at a time when advanced depolymerization technologies are gaining traction as potential solutions to plastic waste and material...

TE Connectivity (TEL) recently reported quarterly results that exceeded analyst expectations on both revenue and earnings, a performance that has put the stock back on many investors’ radar. See our latest analysis for TE Connectivity. The share price has pulled back sharply, with a 30 day share price return down 18.68% and year to date share price return down 13.65%. However, the 1 year total shareholder return of 27.51% and 3 year total shareholder return of 77.33% point to longer term...